Vogt PK - Search Results

1

Domain analysis reveals striking functional differences between the regulatory subunits of phosphatidylinositol 3-kinase (PI3K), p85α and p85β.

Ito Y, Vogt PK, Hart JR. Ito Y, et al. Among authors: vogt pk. Oncotarget. 2017 Aug 3;8(34):55863-55876. doi: 10.18632/oncotarget.19866. eCollection 2017 Aug 22. Oncotarget. 2017. PMID: 28915558 Free PMC article.

2

Amino acid substitutions modulate the effect of Jun on transformation, transcriptional activation and DNA replication.

Morgan IM, Asano M, Håvarstein LS, Ishikawa H, Hiiragi T, Ito Y, Vogt PK. Morgan IM, et al. Among authors: vogt pk. Oncogene. 1993 May;8(5):1135-40. Oncogene. 1993. PMID: 8479738

3

Biochemical and biological characterization of tumor-associated mutations of p110alpha.

Denley A, Gymnopoulos M, Hart JR, Jiang H, Zhao L, Vogt PK. Denley A, et al. Among authors: vogt pk. Methods Enzymol. 2008;438:291-305. doi: 10.1016/S0076-6879(07)38020-8. Methods Enzymol. 2008. PMID: 18413256

4

PI 3-kinase and cancer: changing accents.

Vogt PK, Gymnopoulos M, Hart JR. Vogt PK, et al. Curr Opin Genet Dev. 2009 Feb;19(1):12-7. doi: 10.1016/j.gde.2008.11.011. Curr Opin Genet Dev. 2009. PMID: 19185485 Free PMC article. Review.

5

Akt demoted in glioblastoma.

Vogt PK, Hart JR. Vogt PK, et al. Sci Signal. 2009 Apr 21;2(67):pe26. doi: 10.1126/scisignal.267pe26. Sci Signal. 2009. PMID: 19383977

6

Phosphatidylinositol 4,5-bisphosphate-specific AKT1 is oncogenic.

Dannemann N, Hart JR, Ueno L, Vogt PK. Dannemann N, et al. Among authors: vogt pk. Int J Cancer. 2010 Jul 1;127(1):239-44. doi: 10.1002/ijc.25012. Int J Cancer. 2010. PMID: 19876913 Free PMC article.

7

Hot-spot mutations in p110alpha of phosphatidylinositol 3-kinase (pI3K): differential interactions with the regulatory subunit p85 and with RAS.

Zhao L, Vogt PK. Zhao L, et al. Among authors: vogt pk. Cell Cycle. 2010 Feb 1;9(3):596-600. doi: 10.4161/cc.9.3.10599. Cell Cycle. 2010. PMID: 20009532 Free PMC article.

8

Phosphatidylinositol 3-kinase: the oncoprotein.

Vogt PK, Hart JR, Gymnopoulos M, Jiang H, Kang S, Bader AG, Zhao L, Denley A. Vogt PK, et al. Curr Top Microbiol Immunol. 2010;347:79-104. doi: 10.1007/82_2010_80. Curr Top Microbiol Immunol. 2010. PMID: 20582532 Free PMC article. Review.

9

Smooth muscle α-actin is a direct target of PLZF: effects on the cytoskeleton and on susceptibility to oncogenic transformation.

Shi J, Sun M, Vogt PK. Shi J, et al. Among authors: vogt pk. Oncotarget. 2010 May;1(1):9-21. doi: 10.18632/oncotarget.104. Oncotarget. 2010. PMID: 20634973 Free PMC article.

10

Cancer-derived mutations in the regulatory subunit p85alpha of phosphoinositide 3-kinase function through the catalytic subunit p110alpha.

Sun M, Hillmann P, Hofmann BT, Hart JR, Vogt PK. Sun M, et al. Among authors: vogt pk. Proc Natl Acad Sci U S A. 2010 Aug 31;107(35):15547-52. doi: 10.1073/pnas.1009652107. Epub 2010 Aug 16. Proc Natl Acad Sci U S A. 2010. PMID: 20713702 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

346 results

Search Page

Filters